A Deep Learning-Based Prediction Model for Mortality in Severe COVID-19 Patients Requiring Intensive Care Unit Admission: A Multicenter Registry Analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) has been associated with substantial global mortality. Although artificial intelligence (AI)-based models have shown promise for mortality prediction, evidence focused specifically on critically ill patients remains limited. In addition, meaningful clinical implementation requires models that rely on a minimal set of readily available variables to enable rapid risk stratification. This study aimed to develop a deep learning-based model for predicting mortality in critically ill COVID-19 patients requiring intensive care unit (ICU) admission, with an emphasis on efficiency and clinical applicability. METHODS: This retrospective multicenter study included 900 critically ill patients with COVID-19 admitted to ICUs across 22 centers in Korea between January 1, 2020, and August 31, 2021. A deep learning-based tabular model was constructed, and systematic feature reduction strategies were applied to optimize predictive performance while enhancing practicality. RESULTS: < 0.05). The initial model incorporating 66 variables achieved an area under the curve (AUC) of 0.8500. Following stepwise feature selection, the model was reduced to seven key variables (age, C-reactive protein, lactate dehydrogenase, pro-B-type natriuretic peptide, CXR infiltration, CXR consolidation, and ROX index), resulting in a simplified model with an AUC of 0.8247. CONCLUSION: A deep learning-based AI model was developed to support clinical decision-making in critically ill patients with COVID-19, offering an efficient and clinically practical approach to mortality risk assessment.
Authors
- Tae-Ok Kim (ORCID: https://orcid.org/0000-0002-0922-9472)
- Kang-Moon Park (ORCID: https://orcid.org/0000-0003-2452-9438)
- Onyu Park (ORCID: https://orcid.org/0009-0002-8240-7586)
- Su Hwan Lee (ORCID: https://orcid.org/0000-0002-3487-2574)
- Bo‐Gun Kho (ORCID: https://orcid.org/0000-0002-3057-1141)
- Hye Ju Yeo (ORCID: https://orcid.org/0000-0002-8403-5790)
- Chul Park (ORCID: https://orcid.org/0000-0002-6031-009X)
- Woo Hyun Cho (ORCID: https://orcid.org/0000-0002-8299-8008)
- Sunghoon Park (ORCID: https://orcid.org/0000-0001-7004-6985)
- Joon Hwang (ORCID: https://orcid.org/0009-0001-1722-8752)
- Hong‐Joon Shin (ORCID: https://orcid.org/0000-0002-0146-3491)
- Chang-Seok Yoon (ORCID: https://orcid.org/0009-0002-8336-4426)
- TAEHWA KIM (ORCID: https://orcid.org/0000-0003-3722-0261)
- On behalf of Korean Intensive Care Study Group
Institutions
- Chonnam National University (KR)
- Korea National University of Transportation (KR)
- Yonsei University (KR)
- Severance Hospital (KR)
- Chonnam National University Hospital (KR)
- Ulsan University Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- Pusan National University (KR)
Publication Details
- Journal
- Journal of Korean Medical Science
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3346/jkms.2026.41.e275
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chonnam National University
- National Research Foundation of Korea